Dimethylarsine and trimethylarsine are potent genotoxins in vitro

Chemical Research in Toxicology

Volumn 16, Issue 8, 2003, Pages 994-1003

  Andrewes, Paul ^a   Kitchin, Kirk T ^a   Wallace, Kathleen ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DIMETHYLARSINE; DIMETHYLARSINOUS ACID; DITHIOERYTHRITOL; DITHIOL DERIVATIVE; DNA; METHANEARSONIC ACID; METHYLARSINE; METHYLARSONOUS ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM BOROHYDRIDE; TOXIN; TRIMETHYLARSINE; TRIMETHYLARSINE OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA SUPERCOILING; FILTER; GENOTOXICITY; HUMAN; IN VITRO STUDY; NONHUMAN; PH; REACTION ANALYSIS;

ARSENICALS; DNA, SUPERHELICAL; ELECTROPHORESIS, AGAR GEL; GASES; MUTAGENS; SOLUTIONS;

EID: 0042863393     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034063h     Document Type: Article

References (57)

1. NAS (1999) Arsenic in Drinking Water, National Academy Press, Washington, DC.
2. IARC (1987) Arsenic. Overall Evaluations of Carcinogenicity. An updating of IARC monographs 1-42, Suppl. 7, pp 100-106, International Agency for Research on Cancer, Lyon, France.
3. IARC (2002) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Drinking-Water Disinfectants and Contaminants, Including Arsenic, International Agency for Research on Cancer, Lyon, France.
4. Mandal, B. K., and Suzuki, K. T. (2002) Arsenic round the world: a review. Talanta 58, 201-235.
5. Basu, A., Mahata, J., Gupta, S., and Giri, A. K. (2001) Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat. Res. 488, 171-194.
6. Aposhian, H. V. (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37, 397-419.
7. Vahter, M. (2002) Mechanisms of arsenic biotransformation. Toxicology 181, 211-217.
8. Aposhian, H. V., Gurzau, E. S., Le, X. C., Gurzau, A., Healy, S. M., Lu, X., Ma, M., Yip, L., Zakharyan, R. A., Maiorino, R. M., Dart, R. C., Tircus, M. G., Gonzalez-Ramirez, D., Morgan, D. L., Avram, D., and Aposhian, M. M. (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13, 693-697.
9. Aposhian, H. V., Zheng, B., Aposhian, M. M., Le, X. C., Cebrian, M. E., Cullen, W., Zakharyan, R. A., Ma, M., Dart, R. C., Cheng, Z., Andrewes, P., Yip, L., O'Malley, G. F., Maiorino, R. M., Van Voorhies, W., Healy, S. M., and Titcomb, A. (2000) DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol. Appl. Pharmacol. 165, 74-83.
10. Le, X. C., Ma, M., Cullen, W. R., Aposhian, H. V., Lu, X., and Zheng, B. (2000) Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108, 1015-1018.
11. Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000) Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72, 5172-5177.
12. Del Razo, L. M., Styblo, M., Cullen, W. R., and Thomas, D. J. (2001) Determination of trivalent methylated arsenicals in biological matrixes. Toxicol. Appl. Pharmacol. 174, 282-293.
13. Sampayo-Reyes, A., Zakharyan, R. A., Healy, S. M., and Aposhian, H. V. (2000) Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 13, 1181-1186.
14. Kenyon, E. M., and Hughes, M. F. (2001) A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. Toxicology 160, 227-236.
15. Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. (1989) Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165, 43-50.
16. Yamanaka, K., Ohba, H., Hasegawa, A., Sawamura, R., and Okada, S. (1989) Mutagenicity of dimethylated metabolites of inorganic arsenies. Chem. Pharm. Bull. 37, 2753-2756.
17. Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. (1991) Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108, 205-213.
18. Yamanaka, K., Tezuka, M., Kato, K., Hasegawa, A., and Okada, S. (1993) Cross-link formation between DNA and nuclear proteins by in vivo and in vitro exposure of cells to dimethylarsinic acid. Biochem. Biophys. Res. Commun. 191, 1184-1191.
19. Yamanaka, K., Ohtsubo, K., Hasegawa, A., Hayashi, H., Ohji, H., Kanisawa, M., and Okada, S. (1996) Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis 17, 767-770.
20. Yamanaka, K., Hayashi, H., Tachikawa, M., Kato, K., Hasegawa, A., Oku, N., and Okada, S. (1997) Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat. Res. 394, 95-101.
21. Yamanaka, K., Hayashi, H., Kato, K., Hasegawa, A., Oku, N., and Okada, S. (1997) DNA single-strand breaks in L-132 cells resulting from inhibition of repair polymerization shortly after exposure to dimethylarsinic acid. Biol. Pharm. Bull. 20, 163-167.
22. Yamanaka, K., Katsumata, K., Ikuma, K., Hasegawa, A., Nakano, M., and Okada, S. (2000) The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett. 152, 79-85.
23. Yamanaka, K., Takabayashi, F., Mizoi, M., An, Y., Hasegawa, A., and Okada, S. (2001) Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-2′ -deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochem. Biophys. Res. Commun. 287, 66-70.
24. Yamanaka, K., Mizol, M., Kato, K., Hasegawa, A., Nakano, M., and Okada, S. (2001) Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz[a]anthracene with or without ultraviolet B as a promoter. Biol. Pharm. Bull. 24, 510-514.
25. Yamanaka, K., and Okada, S. (1994) Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ. Health Perspect. 102(Suppl. 3), 37-40.
26. Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. (1989) DNA strand breaks in mammalian tissues induced by methylarsenics. Biol. Trace Elem. Res. 21, 413-417.
27. Yamanaka, K., Hoshino, M., Okamoto M., Sawamura, R., Hasegawa, A., and Okada, S. (1990) Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 168, 58-64.
28. Mass, M. J., Tennant, A., Roop, B. C., Cullen, W. R., Styblo, M., Thomas, D. J., and Kligerman, A. D. (2001) Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14, 355-361.
29. Nesnow, S., Roop, B. C., Lambert, G., Kadiiska, M., Mason, R. P., Cullen, W. R., and Mass, M. J. (2002) DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15, 1627-1634.
30. Ahmad, S., Kitchin, K. T., and Cullen, W. R. (2002) Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicol. Lett. 133, 47-57.
31. Ahmad, S., Kitchin, K. T., and Cullen, W. R. (2002) Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382, 195-202.
32. Kligerman, A. D., Doerr, C., Tennant, A. H., Harrington-Brock, K., Allen, J. W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funusaka, K., Roop, B. C., DeMarini, D. M., and Mass, M. J. (2003) Methylated trivalent arsenic as the ultimate genotoxic form of arsenic: induction of chromosomal and DNA damage but not gene mutations. Environ. Mol. Mutagen. In press.
33. Schwerdtle, T., Walter, I., Mackiw, I., and Hartwig, A. (2003) Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24, 967-974.
34. Cullen, W. R., McBride, B. C., Manji, H., Pickett, A. W., and Reglinski, J. (1989) The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 3, 71-78.
35. Burrows, G. J., and Turner, E. E. (1920) A new type of compound containing arsenic. J. Chem. Soc. Trans. 1373-1380.
36. Nelson, J. C. (1993) Ph.D. Thesis, University of British Columbia.
37. Cullen W. R., and Reimer, K. J. (1989) Arsenic speciation in the environment. Chem. Rev. 89, 713-764.
38. Cullen, W. R., McBride, B. C., and Reglinski, J. (1984) The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals. J. Inorg. Biochem. 21, 45-60.
39. Vahter, M., and Concha, G. (2001) Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 89, 1-5.
40. Challenger, F. (1945) Biological methylation. Chem. Rev. 36, 315-361.
41. Kaise, T., Yamauchi, H., Horiguchi, Y., Tani, T., Watanabe, S., Hirayawa, T., and Fukui, S. (1989) A comparative study on acute toxicity of methylarsonic acid, dimethylarsinic acid and trimethylarsine oxide in mice. Appl. Organomet. Chem. 3, 273-277.
42. Moore, M. M., Harrington-Brock, K., and Doerr, C. L. (1997) Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386, 279-290.
43. Petrick, J. S., Jagadish, B., Mash, E. A., and Aposhian, H. V. (2001) Monomethylarsonous acid (MMA(III)) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14, 651-656.
44. Petrick, J. S., Ayala-Fierro, F., Cullen, W. R., Carter, D. E., and Aposhian, H. V. (2000) Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163, 203-207.
45. Styblo, M., Del Razo, L. M., Vega, L., Germolec, D. R., LeCluyse, E. L., Hamilton, G. A., Reed, W., Wang, C., Cullen, W. R., and Thomas, D. J. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74, 289-299.
46. Hughes, M. F., Del Razo, L. M., and Kenyon, E. M. (2000) Dose-dependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration. Toxicology 143, 155-166.
47. Kitchin, K. T. (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
48. Thomas, D. J., Styblo, M., and Lin, S. (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
49. Nishikawa, T., Wanibuchi, H., Ogawa, M., Kinoshita, A., Morimura, K., Hiroi, T., Funae, Y., Kishida, H., Nakae, D., and Fukushima, S. (2000) Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: A possible reactive oxygen species mechanism. Int. J. Cancer 100, 136-139.
50. Shen, J., Wanibuchi, H., Salim, E. I., Wei, M., Doi, K., and Fukushima, S. (2003) Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats; Association with oxidative DNA damage and enhanced cell proliferation. Proc. Am. Assoc. Cancer Res. 44, 98.
51. Haas, K., and Feldmann, J. (2000) Sampling of trace volatile metal(loid) compounds in ambient air using polymer bags: a convenient method. Anal. Chem. 72, 4205-4211.
52. Kitchin, K. T., and Ahmad, S. (2003) Oxidative stress as a possible mode of action for arsenic. Toxicol. Lett. 137, 3-13.
53. Yamauchi, H., Takahashi, K., and Yamamura, Y. (1988) Metabolism and excretion of orally and intraperitoneally administered trimethylarsine oxide in the hamster. Toxicol. Environ. Chem. 22, 69-76.
54. Solis-Cohen, S., and Githens, T. S. (1928) Pharmacotherapeutics, Materia Medica and Drug Action, Appleton and Company, New York.
55. Marafante, E., Vahter, M., Norin, H., Envall, J., Sandstrom, M., Christkopoulos, A., and Ryhage, R. (1987) Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7, 111-117.
56. Yamauchi, H., and Yamamura, Y. (1985) Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology 34, 113-121.
57. Jiang, G., Gong, Z., Li, X., Cullen, W. R., and Le, X. C. (2003) Interaction of trivalent arsenicals with metallothionein. Chem. Res. Toxicol. 16, 855-864.